Topic: MYLAN
98 results were found.
FTC imposes conditions on combination of Pfizer Upjohn and Mylan - October 31, 2020
ACCC will not oppose Mylan’s proposed merger with Pfizer’s Upjohn division - September 11, 2020
Mylan to acquire Aspen's thrombosis business in Europe - September 9, 2020
Commission approves merger of Mylan and Pfizer's Upjohn division, subject to conditions - April 23, 2020
Mylan and Pfizer provide update about Mylan and Upjohn - March 27, 2020
Mylan and Upjohn proposed merger waiting for New Zealand OK - January 16, 2020
Mylan revenues $2.96 billion - November 5, 2019
Mylan to pay $30 million fine relating to EpiPen - September 27, 2019
Mylan slips to loss, will combine with Upjohn - July 29, 2019
Mylan posts Q1 loss - May 7, 2019
Mylan closes deal with Novartis To commercialize certain global cystic fibrosis products - September 6, 2018
Italian authorities raid Mylan offices for info on drug sales, hospital relationship - May 13, 2018
Mylan Q1 net income increased to $87.1 million - May 10, 2018
Mylan Q4 revenues, $3.24 billion, down 1% - March 1, 2018
Mylan Q3 bottom line fell to $589.7 million - November 6, 2017
Mylan finalizes $465m settlement on Medicaid rebate classification for EpiPen - August 17, 2017
Mylan profit retreats in Q2 - August 9, 2017
HHS inspector: Mylan may have overcharged taxpayers by $1.2bn for EpiPens - June 1, 2017
Mylan reports 29% gain in Q1 profit - May 10, 2017
Mylan appoints Daniel M. Gallagher as chief legal officer - March 29, 2017
Mylan Q4 bottom line came in at $842.2 million - March 1, 2017
Judge says Mylan may make generics, Teva says no way - January 31, 2017
Mylan may cut less than 10 percent of workforce - December 7, 2016
Mylan posts 1% decrease in Q3 earnings - November 10, 2016
Mylan agrees to settle EpiPen issues with DOJ, others for $465m - October 8, 2016
Mylan was overcharging Medicaid for EpiPen for years - October 6, 2016
West Virginia seeks Mylan records on EpiPen price - September 20, 2016
Mylan CEO to testify before House panel to explain EpiPen pricing - September 14, 2016
New York launches antitrust investigation into Mylan - September 6, 2016
Mylan to launch generic EpiPen at 50% discount - August 29, 2016
Mylan offers discounts on EpiPen after wave of criticism - August 25, 2016
Mylan Q2 revenues up 8% to $2.56 billion - August 10, 2016
Mylan completes acquisition of Meda - August 5, 2016
Mylan receives U.S. FTC clearance for Meda acquisition - July 28, 2016
European Commission clears acquisition of Meda by Mylan with conditions - July 21, 2016
Mylan to buy Renaissance Acquisition's business for $950+ million - May 13, 2016
Mylan hires Kenneth Parks as CFO - May 4, 2016
Mylan Q1 revenues increased 19 percent - May 3, 2016
Mylan appoints Anthony Mauro chief commercial officer - February 23, 2016
Moody's affirms Mylan's Baa3; outlook stable - February 12, 2016
Mylan full year adjusted total revenues $9.45 billion - February 11, 2016
Mylan enters agreement to acquire Meda in $9.9 billion deal - February 10, 2016
Perrigo shareholders reject Mylan's hostile takeover - November 13, 2015
Perrigo: Mylan's poor governance practices are legendary - November 9, 2015
FTC satisfied with Mylan's proposed transaction to acquire Perrigo - November 3, 2015
Ranjan Ray Chaudhuri global commercial lead for Mylan's OTC - November 2, 2015
U.S. Court: Mylan provided adequate disclosures for Perrigo - November 2, 2015
Perrigo: Mylan's earnings presentation is not convincing - November 2, 2015
Mylan Q3 GAAP gross profit $1.32 billion - October 31, 2015
Perrigo's attempt to block Mylan listing on TASE was blocked - October 28, 2015
Perrigo CEO: Mylan's hostile takeover would cause chaos - October 27, 2015
Perrigo will cut 800 jobs to fight Mylan - October 22, 2015
Perrigo wants judge to stop Mylan going hostile - October 21, 2015
Mylan said stichting no more needed as threats have been addressed - September 21, 2015
Perrigo rejects Mylan's tender offer - September 17, 2015
Mylan officially starts battle for Perrigo, goes directly to shareholders - September 14, 2015
Mylan officially starts battle for Perrigo, goes directly to shareholders - September 14, 2015
Perrigo CEO to Mylan: All your statements are false - September 10, 2015
Mylan: We are going after Perrigo next Monday with $27+ billion - September 8, 2015
Perrigo calls shareholders to trust Plus Plus Plus, reject Mylan's offer - August 28, 2015
Mylan shareholders: Let's go hostile after Perrigo - August 28, 2015
Mylan: Perrigo continues to make misleading comments - August 25, 2015
Mylan: We will control Perrigo even with just 51% of shares - August 21, 2015
Perrigo CEO: Mylan is desperate and has poor corporate governance - August 17, 2015
Perrigo: Mylan's new move is reckless - August 14, 2015
Mylan lowers acceptance condition on Perrigo offer to greater than 50% - August 13, 2015
Mylan Q2 total revenues increased 36% - August 6, 2015
Mylan now says Perrigo is not a must... - August 6, 2015
Perrigo CEO: There is no easy path for Mylan - August 6, 2015
Mylan updates offer for Perrigo, could lower the acceptance condition - August 5, 2015
Mylan gets green light from Europe to buy Perrigo - July 30, 2015
Teva withdraws from Mylan, will buy Allergan Generics in $40.5 billion transaction - July 27, 2015
Mylan wants to block Teva, Teva wants to block Mylan - July 24, 2015
Teva completes purchase of 4.61% interest in Mylan - June 20, 2015
Abbott to vote for Mylan's acquisition of Perrigo - June 16, 2015
Teva switches legal counsel after Mylan challenge - June 10, 2015
Teva to Mylan: Our offer is strong and serious - June 9, 2015
Mylan: Teva's stake buy violates U.S. anti-trust rules - June 2, 2015
Teva buys 1.35% of Mylan's stock - May 29, 2015
Irish Takeover Panel wants clarification from Mylan about Perrigo - May 26, 2015
Mylan Q1 2015 constant currency revenue increases 15% - May 6, 2015
Mylan sues Teva's law firm Kirkland & Ellis - May 4, 2015
Teva is losing nerves: Mylan should stop mudslinging - April 30, 2015
Mylan raises offer for Perrigo to $35.6 billion, Perrigo says no - April 29, 2015
Mylan: We are not giving our valuable stock for low-quality Teva shares - April 27, 2015
Mylan goes hostile in bid for Perrigo with $31 billion - April 24, 2015
Perrigo rejects unsolicited proposal from Mylan - April 22, 2015
Teva willing to give $31 billion for Mylan - April 21, 2015
Mylan proposes to acquire Perrigo for $30 billion - April 8, 2015
Mylan Q4 total revenues of $2.08 billion were up 18% - March 4, 2015
Mylan completes acquisition of Abbott's businesses - March 2, 2015
Mylan to buy Famy Care for $750 million - February 3, 2015
Mylan nominates JoEllen Lyons Dillon for election to board - March 12, 2014
Mylan appoints EVP, global collaboration, strategic operations - January 9, 2014
Melina Higgins and Rajiv Malik join Mylan board of directors - February 12, 2013
Mylan: CFO Jolene Varney to leave - September 9, 2009
Mylan announces several promotions in executive team - July 29, 2009
Andrew G. Cuneo joins Mylan as vice president - April 13, 2009